EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, SGMO: Sangamo Therapeutics

07 Nov 25 15:59
LAST:

0.4721

CHANGE:
 0.01		OPEN:
0.4560		HIGH:
0.4989		ASK:
8.1500		VOLUME:
5.75M
CHG(%):
2.45		PREV:
0.4605		LOW:
0.4505		BID:
10.2800		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 250.46200.49890.45050.47186.07M
06 Nov 250.42000.51310.41510.460512.08M
05 Nov 250.54500.56070.53410.55015.59M
04 Nov 250.57500.59770.55380.56163.05M
03 Nov 250.60460.60550.56750.57834.36M
31 Oct 250.58060.62190.57450.59804.49M
30 Oct 250.57100.59690.56700.57203.31M
29 Oct 250.58800.61920.56200.58005.3M
28 Oct 250.62500.62830.58200.59054.96M
27 Oct 250.64900.66890.61600.62914.44M

COMPANY PROFILE

Name:Sangamo Therapeutics
About:Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A. Its preclinical development products focus on tauopathies, ALS/FTD, and huntington's diseases Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; and Open Monoclonal Technology, Inc. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. The company was incorporated in 1995 and is headquartered in Richmond, California.
Sector:Healthcare
Industry:Biotechnology
Address:501 Canal Blvd, Richmond, CA, United States, 94804
Website:https://www.sangamo.com
CUSIP:800677106
CIK:0001001233
ISIN:US8006771062
FIGI:BBG000BHYT80
LEI:2549006WMRKRC4G32Z67

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.5211.1%
MA10:0.5618.4%
MA20:0.6129.2%
MA50:0.6027.0%
MA100:0.5619.4%
MA200:0.6742.8%
STO9:6.73 
STO14:4.92 
RSI14:17.10 
WPR14:-94.34 
MTM14:-0.17
ROC14:-0.27 
ATR:0.05 
Week High:0.6231.7%
Week Low:0.4213.7%
Month High:0.7662.0%
Month Low:0.4242.8%
Year High:3.18573.4%
Year Low:0.4114.8%
Volatility:35.60